115 related articles for article (PubMed ID: 37469237)
21. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin.
Wei W; Li H; Li N; Sun H; Li Q; Shen X
Pancreatology; 2013; 13(4):384-92. PubMed ID: 23890137
[TBL] [Abstract][Full Text] [Related]
22. EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.
Tang SN; Fu J; Shankar S; Srivastava RK
PLoS One; 2012; 7(2):e31067. PubMed ID: 22348037
[TBL] [Abstract][Full Text] [Related]
23. Knockdown on aPKC-ι inhibits epithelial-mesenchymal transition, migration and invasion of colorectal cancer cells through Rac1-JNK pathway.
Du GS; Qiu Y; Wang WS; Peng K; Zhang ZC; Li XS; Xiao WD; Yang H
Exp Mol Pathol; 2019 Apr; 107():57-67. PubMed ID: 30465755
[TBL] [Abstract][Full Text] [Related]
24. Effects of Holliday Junction-Recognition Protein-Mediated C-Jun N-Terminal Kinase/ Signal Transducer and Activator of Transcription 3 Signaling Pathway on Cell Proliferation, Cell Cycle and Cell Apoptosis in Bladder Urothelial Carcinoma.
Gao S; Zhou XQ; Wu Q; Chen XD; Li P; Qin YM
Tohoku J Exp Med; 2023 Feb; 259(3):209-219. PubMed ID: 36543245
[TBL] [Abstract][Full Text] [Related]
25. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3.
Liu L; Liu L; Lu S
Int J Oncol; 2019 Mar; 54(3):929-941. PubMed ID: 30747209
[TBL] [Abstract][Full Text] [Related]
26. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
Liu XD; Zhang ZW; Wu HW; Liang ZY
Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression.
Patel K; Kollory A; Takashima A; Sarkar S; Faller DV; Ghosh SK
Cancer Lett; 2014 May; 347(1):54-64. PubMed ID: 24491408
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.
Chen H; Pan J; Zhang L; Chen L; Qi H; Zhong M; Shi X; Du J; Li Q
Eur J Pharmacol; 2018 Apr; 825():133-142. PubMed ID: 29476880
[TBL] [Abstract][Full Text] [Related]
29. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.
Pan T; Zhang F; Li F; Gao X; Li Z; Li X; Ren X
Oncol Rep; 2020 Sep; 44(3):1049-1063. PubMed ID: 32705271
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5.
Hu H; Zhang Q; Chen W; Wu T; Liu S; Li X; Luo B; Zhang T; Yan G; Lu H; Lu Z
Carcinogenesis; 2020 Jun; 41(4):502-514. PubMed ID: 31233116
[TBL] [Abstract][Full Text] [Related]
31. [ZFP36L1 inhibits proliferation, invasion and migration of human breast cancer cells by inducing epithelial-mesenchymal transition through STAT3/p-STAT3 signaling pathway].
Zhang F; Qi G; Ding K; Liu J; Chen M; Lin M; Zhou F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Aug; 38(8):721-726. PubMed ID: 35851086
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X
J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351
[TBL] [Abstract][Full Text] [Related]
34. [
Zhang RH; Huang JP; Li JW; Li YQ; Cui XY; Xiong YN; Liu YK; Zhang GL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):558-564. PubMed ID: 37248584
[TBL] [Abstract][Full Text] [Related]
35. Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signaling.
Kawasaki S; Ohtsuka H; Sato Y; Douchi D; Sato M; Ariake K; Masuda K; Fukase K; Mizuma M; Nakagawa K; Hayashi H; Morikawa T; Motoi F; Unno M
Pancreatology; 2021 Jun; 21(4):771-778. PubMed ID: 33707114
[TBL] [Abstract][Full Text] [Related]
36. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract][Full Text] [Related]
37. LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling.
Gao F; Chen J; Zhang T; Liu N
Exp Cell Res; 2022 Dec; 421(1):113360. PubMed ID: 36122769
[TBL] [Abstract][Full Text] [Related]
38. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis.
Zhang J; Chu D; Kawamura T; Tanaka K; He S
J Cell Physiol; 2019 Aug; 234(8):12800-12808. PubMed ID: 30537081
[TBL] [Abstract][Full Text] [Related]
39. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
[TBL] [Abstract][Full Text] [Related]
40. Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer.
Liu X; Guo X; Li H; Chen J; Qi X
Mol Med Rep; 2016 Jun; 13(6):4774-8. PubMed ID: 27082851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
